Abstract & Overview
Alkaptonuria (AKU) (OMIM#203500) is a rare inherited disorder due to deficiency of homogentisate dioxygenase with resultant accumulation of homogentisic acid, occurring with a worldwide frequency of 1 in 100,000 to 250,000 [1].
Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.
Checking your access to this record.
Alkaptonuria (AKU) (OMIM#203500) is a rare inherited disorder due to deficiency of homogentisate dioxygenase with resultant accumulation of homogentisic acid, occurring with a worldwide frequency of 1 in 100,000 to 250,000 [1].
Copy in another style
Ranganath, L. R., & Sireau, N. T. (2022). Clinical Development Innovation in Rare Diseases: Overcoming Barriers to Successful Delivery of A Randomised Clinical Trial in Alkaptonuria. Journal of Clinical Medicine Current Research, 2(2). https://doi.org/10.53043/ndcr-2-008
Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.
Alexandre Gallerand, Stoyan Ivanov
In Discovery Immunology
Lucía Toca Pérez, Miriam Alonso Fernández
In Clínica Contemporánea
Eduardo de Santibáñes, Claudio Bassi
In Annals of Surgery
John P. Stein, Stuart D. Boyd
In Journal of Clinical Oncology